Jin Yang Pharmaceutical Co., Ltd. (007370) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Jin Yang Pharmaceutical Co., Ltd. (007370:KRX), powered by AI.

Current Price
₩4,105
P/E Ratio
2.6
Market Cap
58.0B
Sector
Healthcare
What is the Jin Yang Pharmaceutical Co., Ltd. stock price forecast?

Jin Yang Pharmaceutical Co., Ltd. is currently trading at ₩4,105. View real-time AI analysis on Alpha Lenz.

What is Jin Yang Pharmaceutical Co., Ltd. insider trading activity?

View the latest insider trading data for Jin Yang Pharmaceutical Co., Ltd. on Alpha Lenz.

What is Jin Yang Pharmaceutical Co., Ltd.'s P/E ratio?

Jin Yang Pharmaceutical Co., Ltd.'s P/E ratio is 2.6.

Jin Yang Pharmaceutical Co., Ltd.

KRX · 007370
₩4,105+5(+0.12%)Market closedKRX regular session 09:00–15:30 KST
Ask about Jin Yang Pharmaceutical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Jin Yang Pharmaceutical Co., Ltd. trades at a P/E of 2.6 (undervalued) with strong ROE of 15.9%. 3Y revenue CAGR of 16.5% highlights clear growth momentum.

Ask for details

Company Overview

Jin Yang Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, concentrating on the research, development, manufacturing, and marketing of pharmaceutical products. The company is dedicated to advancing medical care and improving patient outcomes by providing innovative and high-quality medications. Jin Yang focuses on a wide range of therapeutic areas, including oncology, cardio-metabolic disorders, and infectious diseases, addressing the needs of both local and international markets. As a pharmaceutical entity, Jin Yang is integral to the healthcare sector, contributing to the industry's overall growth and technological advancements. The company's involvement in producing essential medicines not only supports healthcare providers but also plays a crucial role in ensuring the availability and accessibility of life-saving treatments. By emphasizing rigorous research and development, Jin Yang Pharmaceutical Co., Ltd. upholds its commitment to enhancing health care systems and patient care worldwide.

CEO최재준, 최윤환(각자대표)
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
0

Company Statistics

FY 2025

Profile

₩58,022,479,635Market Cap
₩120,686,230,370Revenue
14.13MShares Out
0Employees

Margins

64.76%Gross
27.46%EBITDA
2.09%Operating
23.28%Pre-Tax
18.47%Net

Valuation

2.60P/E
0.36P/B
0.48EV/Sales
4.00EV/EBITDA
-26.29P/FCF

Growth (CAGR)

16.53%Rev 3Yr
19.50%Rev 5Yr
-39.02%Op Inc 3Yr
-9.93%Op Inc 5Yr
21.88%Net Inc 3Yr
33.64%Net Inc 5Yr

Returns

9.00%ROA
15.93%ROE
12.27%ROIC

Financial Health

₩2,203,620,450Cash & Cash Equivalents
₩105,748,696,620Net Debt
67.53%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Jin Yang Pharmaceutical Co., Ltd. (ticker: 007370) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). Market cap is $58.0B.

The current price is ₩4,105 with a P/E ratio of 2.6x and P/B of 0.36x.

ROE is 15.93% and operating margin is 2.09%. Annual revenue is $120.7B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Jin Yang Pharmaceutical Co., Ltd. (007370) Stock Forecast 2026 ₩4,105 — Price, Financials & Analyst Targets | Alpha Lenz